clofibric acid has been researched along with Disease Exacerbation in 7 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study of the hypolipidemic efficiency, safety and tolerance of ciprofibrate (lipanor) in therapy of atherogenic hyperlipoproteinemia." | 5.08 | [Lipanor treatment of atherogenic hyperlipoproteinemia]. ( Arabidze, GG; Kukharchuk, VV; Susekov, AV; Tvorogova, MG, 1998) |
| "Niacin has been shown to regress atherosclerosis when used as monotherapy, in combination with a statin, and in combination with nonstatin therapies (including cholesterol-binding resins) and fibrates." | 2.44 | Evidence to support aggressive management of high-density lipoprotein cholesterol: implications of recent imaging trials. ( Taylor, AJ, 2008) |
| "Thus, targeting the hyperglycemia in type 2 diabetes mellitus (DM) alone will not eliminate all of the excess cardiovascular risk; rather aggressive treatment is needed for all of the modifiable cardiometabolic risk factors." | 2.44 | Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors. ( Gerich, JE, 2007) |
| "Fenofibrate treatment decreased hepatic macrophage accumulation and abolished steatosis." | 1.33 | Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates. ( Buffat, L; Gijbels, MJ; Hofker, MH; Maeda, N; Noel, B; Shiri-Sverdlov, R; Staels, B; van Bilsen, M; van Gorp, PJ; Wouters, K, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avis, HJ | 1 |
| Vissers, MN | 1 |
| Wijburg, FA | 1 |
| Kastelein, JJ | 1 |
| Hutten, BA | 1 |
| Hausenloy, DJ | 1 |
| Yellon, DM | 1 |
| Wierzbicki, AS | 1 |
| Shiri-Sverdlov, R | 1 |
| Wouters, K | 1 |
| van Gorp, PJ | 1 |
| Gijbels, MJ | 1 |
| Noel, B | 1 |
| Buffat, L | 1 |
| Staels, B | 1 |
| Maeda, N | 1 |
| van Bilsen, M | 1 |
| Hofker, MH | 1 |
| Taylor, AJ | 1 |
| Gerich, JE | 1 |
| Susekov, AV | 1 |
| Tvorogova, MG | 1 |
| Arabidze, GG | 1 |
| Kukharchuk, VV | 1 |
5 reviews available for clofibric acid and Disease Exacerbation
| Article | Year |
|---|---|
The use of lipid-lowering drug therapy in children and adolescents.
Topics: Adolescent; Atherosclerosis; Azetidines; Bile Acids and Salts; Cardiovascular Diseases; Child; Chole | 2009 |
Enhancing cardiovascular disease risk reduction: raising high-density lipoprotein levels.
Topics: Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Clofibric Aci | 2009 |
Have we forgotten the pivotal role of high-density lipoprotein cholesterol in atherosclerosis prevention?
Topics: Arteriosclerosis; Cholesterol, HDL; Clofibric Acid; Coronary Artery Disease; Disease Progression; Hu | 2005 |
Evidence to support aggressive management of high-density lipoprotein cholesterol: implications of recent imaging trials.
Topics: Anticholesteremic Agents; Cholesterol, HDL; Clofibric Acid; Coronary Artery Disease; Disease Progres | 2008 |
Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors.
Topics: Cardiovascular Diseases; Clofibric Acid; Coronary Artery Disease; Diabetes Complications; Diabetes M | 2007 |
1 trial available for clofibric acid and Disease Exacerbation
| Article | Year |
|---|---|
[Lipanor treatment of atherogenic hyperlipoproteinemia].
Topics: Cholesterol; Clofibric Acid; Coronary Artery Disease; Disease Progression; Drug Administration Sched | 1998 |
1 other study available for clofibric acid and Disease Exacerbation
| Article | Year |
|---|---|
Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates.
Topics: Animals; Apolipoprotein E2; Apolipoproteins E; ATP-Binding Cassette Transporters; Clofibric Acid; Di | 2006 |